Trade AbbVie ^ABBV

Top Biotech Stocks To Consider - October 22nd - Markets Daily

AbbVie (ABBV) Reports Positive INTREPID Trial Results but Faces

AbbVie's Lutikizumab Meets Pre-specified Endpoints In Phase 3 Hidradenitis Suppurativa Trial

Jim Cramer and Ken Fisher Like This Healthcare Stock

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

AbbVie Inc. $ABBV Stock Acquired by Sowell Financial Services LLC

Sawyer & Company Inc Purchases New Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Nisa Investment Advisors LLC

Crossmark Global Holdings Inc. Purchases 13,446 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Purchased by Capstone Capital Management Ltd

2,400 AbbVie Inc. $ABBV Shares Purchased by Newman Dignan & Sheerar Inc. - Stock Observer

Sowell Financial Services LLC Buys 3,985 Shares of AbbVie Inc. $ABBV - Daily Political

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial

AbbVie's HArmonyCa Shows Midface Improvement In GLP-1 Patient Analysis; Stock Down

AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?

AbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss Drugs

Forget Social Security: 5 High-Yield Stocks Retirees Are Buying Instead

AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian Cancer

Top 10 Stocks Jim Cramer and Billionaire Ken Fisher Like

3,811 AbbVie Inc. $ABBV Shares Sold by Prime Capital Investment Advisors LLC

AbbVie Inc. $ABBV Stock Sold by Sumitomo Mitsui DS Asset Management Company Ltd

AbbVie Inc. $ABBV Stock: Bank Pictet & Cie Europe AG Reduces Position

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Top Global Life Science Funds 2024: Unprecedented Massive Funding Surge Creates Excess Capital Overflow

McLaren Teams Up With AbbVie Before Formula 1 United States GP At COTA

AbbVie (ABBV) Posts Fresh Crohn's Remission Data Ahead Of Its Biggest ESMO Reveal

AbbVie's SKYRIZI Gets Health Canada Approval For Children With Moderate To Severe Plaque Psoriasis

AbbVie (ABBV) - Investment Analysts' Recent Ratings Updates - Daily Political

Pharmaceutical Stocks To Consider - October 20th - Daily Political

Greg Jennings LLC Makes New Investment in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Holdings Cut by RWQ Financial Management Services Inc.

AbbVie (ABBV) Receives a Buy from RBC Capital

Parkinson's Disease Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics, Amneal | ABNewswire

AbbVie Inc. $ABBV Stock: Gimbal Financial Boosts Position

AbbVie Inc. $ABBV Stock Holdings Trimmed by BDF Gestion

AbbVie (ABBV) Unveils Phase 2a Crohn's Data And Flags 2026 ESMO Readouts

AbbVie vs. Bristol Myers: Is AbbVie's Valuation Premium Worth Paying?

Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead

AbbVie Inc. $ABBV Stock: Generali Investments Management Co LLC Cuts Stake

AbbVie's Dual-Targeting Therapy Shows Higher Remission Rates In Mid-Stage Crohn's Disease Study

AbbVie announces new, updated data from solid tumor portfolio at ESMO 2026

AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio | Morningstar

AbbVie presents 20 scientific abstracts from its IBD portfolio

Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer

AbbVie Inc. $ABBV Stock Sold by Fulcrum Wealth Advisors LLC - Markets Daily

AbbVie Inc. $ABBV Position Increased by TD Waterhouse Canada Inc.

AbbVie Inc. $ABBV Holdings Lowered by St. Louis Financial Planners Asset Management LLC - Stock Observer

ShankerValleau Wealth Advisors Inc. Makes New $546,000 Investment in AbbVie Inc. $ABBV - Stock Observer

Healthcare Stocks To Consider - October 17th - Markets Daily

AbbVie's Dividend Keeps Climbing. Is It Still a Buy for Income Investors?

Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle

AbbVie Inc. $ABBV Stock Sold by Cardinal Capital Management Inc.

AbbVie Inc. $ABBV Shares Acquired by Cyndeo Wealth Partners LLC

BFI Infinity Ltd. Makes New $4.16 Million Investment in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Banque Pictet & Cie SA

Cantor Fitzgerald Investment Advisors L.P. Sells 2,450 Shares of AbbVie Inc. $ABBV - Daily Political

Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?

AbbVie vs. Merck: Which Pharma Stock Offers Better Value?

Trade Tracker: Kevin Simpson buys AbbVie

AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?

Healthcare Stocks To Add to Your Watchlist - October 16th - Stock Observer

AbbVie Inc. $ABBV Stock Sold by State of Alaska Department of Revenue

AbbVie Inc. $ABBV Shares Sold by Curated Wealth Partners LLC

AbbVie Inc. $ABBV Shares Sold by WealthPlan Investment Management LLC - Stock Observer

Abbvie, Vertex lead $32B September biopharma M&A surge | BioWorld

AbbVie (ABBV) Stock Could Be 44% Undervalued As Cancer Trial News Lands

What Does AbbVie (ABBV) 51% DLBCL Risk Reduction Mean For Its Oncology Push?

Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets | Morningstar

Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax

AbbVie Inc. $ABBV Shares Newly Acquired by B.A. Schrock Wealth Management Inc.

AbbVie Inc. $ABBV Shares Bought by Mather Group LLC. - Markets Daily

AbbVie Inc. $ABBV Stake Decreased by ZWJ Investment Counsel Inc. - Daily Political

AbbVie Inc. $ABBV Stock: Sanders Morris Harris LLC Raises Holdings

AbbVie Sees Unusually Large Options Volume (NYSE:ABBV)

Thurston Springer Miller Herd & Titak Inc. Sells 5,323 Shares of AbbVie Inc. $ABBV

Generate Investment Management Ltd Sells 21,383 Shares of AbbVie Inc. $ABBV

AbbVie On Pace for Record High Close - Data Talk | Morningstar

Top Biotech Stocks To Research - October 14th - Stock Observer

AbbVie Inc. $ABBV Stock Bought by First Citizens Bank & Trust Co.

Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying

ASK Capital Investment Managers LLC Buys 21,800 Shares of AbbVie Inc. $ABBV

Erste Group Bank Forecasts Increased Earnings for AbbVie - Stock Observer

AbbVie Inc. $ABBV Stake Reduced by Perpetual Ltd

Promising Pharmaceutical Stocks To Follow Now - October 11th - Markets Daily

21,800 Shares in AbbVie Inc. $ABBV Bought by ASK Capital Investment Managers LLC - Daily Political

AbbVie Inc. $ABBV Stock Sold by KMG Fiduciary Partners LLC - Daily Political

AbbVie Reports 35.8% Endoscopic Remission With Subcutaneous Skyrizi In Crohn's Trial

AbbVie's Subcutaneous Skyrizi Shows Endoscopic Benefits In Crohn's Diseases

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

Gold Price Today: XAU/USD Hovers Near $4,015 After Sharp Sell-Off

Nasdaq Falls 2.6% in Worst Session Since June as AI Spending Fears Return

Moderna Shares Fall 18% After Cancer Vaccine Data Leak Triggers Sell-Off

US PMI and Consumer Sentiment Today: Will Oil Above $113 Revive Fed Rate-Hike Bets?

Meta Stock Sinks 7% as AI Spending and Negative Free Cash Flow Overshadow Record Revenue

Super Micro Stock Jumps 9.6% as Strong AI Server Update Lifts Dell and HPE

Meta Stock Rises as Record $64.6 Billion Revenue Outweighs Surging AI Spending

Oil Price Today Rises Above $110 as Middle East Conflict Revives Supply Fears